-
J. Edward Moreno
Posts
Booking dives after slashing its guidance as Iran war weighs on its business
The company expects fewer people to book travel accommodations through its sites this year than it previously forecasted as the war in Iran seeps uncertainty.
Match Group invests $100 million in Grindr rival Sniffies, with future option to acquire the startup
The announcement sent Grindr slipping in after-hours trading.
Amazon-backed X-Energy continues post-IPO rally
X-Energy had a market capitalization of $11.6 billion at Friday’s close.
Lilly slips after prescriptions for its weight-loss pill come in below expectations in second week
The FDA approved Foundayo on April 1 and shipments began on April 9.
It seems like the US weed industry finally got what it wanted. Why did pot stocks plunge?
The DOJ’s order to reclassify marijuana could be a boon for US cannabis companies. But the devil is in the details.
Amazon’s relentless push to become your doctor and your pharmacy
A Q&A with John Love, vice president of Amazon Pharmacy.
Hims rises after it says it now offers “full range” of FDA-approved GLP-1s
Hims providers can now send prescriptions to Eli Lilly’s direct-to-consumer pharmacy.
Lyft to acquire London black cab app Gett UK
Lyft describes its international expansion strategy as “expanding ‘out’ in more locations and ‘up’ into more high-value segments.”
Psychedelic biotechs inch toward commercialization with Trump’s blessing
Psychedelic biotech stocks were already on a tear before Trump’s executive order sent them shooting higher.
UnitedHealth beats Q1 estimates, raises annual outlook
The company, which is the first of its peers to report earnings this quarter, was up more than 6% in premarket trading.